Merrimack Pharmaceuticals
(NASDAQ:MACK)
$14.71
0.03[0.20%]
At close: Apr 19
$14.68
-0.0300[-0.20%]
After Hours: 9:26AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Merrimack Pharmaceuticals Stock (NASDAQ:MACK), Quotes and News Summary

Merrimack Pharmaceuticals Stock (NASDAQ: MACK) stock price, news, charts, stock research, profile.

Open$14.680
Close-
Volume / Avg.62.278K / 124.962K
Day Range14.680 - 14.730
52 Wk Range11.530 - 15.890
Market Cap$213.762M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
58
Short Interest
7.08%
Days to Cover4.97

Recent News

$2M Bet On Ford? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades.
Avi Kapoor
Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Gainers
Lisa Levin
Luna Innovations, Guess? And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
About Merrimack Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercialize...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MACK
IPHA

FAQ

Q

How do I buy Merrimack Pharmaceuticals (MACK) stock?

A

You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Merrimack Pharmaceuticals's (MACK) competitors?

A

Other companies in Merrimack Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).

Q

What is the target price for Merrimack Pharmaceuticals (MACK) stock?

A

The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -72.75% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Merrimack Pharmaceuticals (MACK)?

A

The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $14.68 last updated Today at April 19, 2024 at 9:26 AM EDT.

Q

Does Merrimack Pharmaceuticals (MACK) pay a dividend?

A

A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.

Q

When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?

A

Merrimack Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Merrimack Pharmaceuticals (MACK) going to split?

A

There is no upcoming split for Merrimack Pharmaceuticals.

Q

What sector and industry does Merrimack Pharmaceuticals (MACK) operate in?

A

Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch